Oct 29 (Reuters) - Valeant Pharmaceuticals (N:VRX) International
Inc's VRX.TO VRX.N largest shareholder, Ruane, Cunniff &
Goldfarb Inc, has urged the company to consider paying down
debt.
The investment firm, in a letter to shareholders on
Wednesday, also came to Valeant's defense, saying allegations
against it are false. (http://bit.ly/1SbKI51)
Valeant's stock has taken a beating since short-seller
Citron Research said last week that the company was using its
drug distributor, Philidor, to inflate revenue numbers.
urn:newsml:reuters.com:*:nL1N12L1JW